Farms.com Home   News

Canfax Analyst Says Feeder Market Remains Strong

The beef industry is continuing its recovery from the COVID-19 shutdown.
 
Brian Perillat is a senior analyst with Canfax.
 
"I think plants are doing really well. They continue to be processing cattle near or at capacity, the pre-COVID capacity. Throwing in some Saturday shifts as well. We've been actually processing more fed cattle the last few weeks than a year ago. That's been really positive news for the industry. We still continue to have a bit of backlog but for the most part, I'd say feedlots are in pretty good shape."
 
He says the feeder market remains fairly strong.
 
"Fed cattle market continues to be under pressure with the cattle around well below a year ago...On the other hand, the feeder market continues to be quite resilient, I guess you could say. Some of the yearlings are a little bit below a year ago."
 
Perrilat notes the Canadian dollar has been creeping up near 75 cents U.S.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.